Back

Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Neurologic Disorders and Heart Disease ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Francesco Fioravanti

San Raffaele Hospital, Milan (Italy)

155 More presentations in this session

Presentation thumbnail
Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study
Miss M. Koopman (Groningen, NL)
Abstract Slides
Presentation thumbnail
Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals
Doctor C. Liu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Characteristics and health status of patients with and without confirmed HFpEF
Professor C. Deaton (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
Mr A. Nikhanj (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Ictal ECG changes and antiepileptic drug therapy
Doctor R. Teryan (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular magnetic resonance in neuromuscular disorders: looking ahead
10 May 2023
thumbnail
Congress Presentation
Heart failure, BNP levels and QT-interval correlation during AV block
21 May 2023
thumbnail
Congress Presentation
Quality of glycemic control has significant impact on myocardial mechanics in type 1 diabetes mellitus
22 May 2023
thumbnail
Congress Presentation
Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources